TITLE  PHASE  CONTACT  LOCATION
SMALL CELL   Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide (RTOG 0538)  III Marlene Watson RN
marlene.watson@nmhs.org
402-354-5831
Nebraska Methodist Hospital
Omaha, NE
SMALL CELL  Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (GOG 0937)  II

Marlene Watson RN
marlene.watson@nmhs.org
402-354-5831

---------------------

Deborah Meyer, RN, BGS

 (402) 559-6941

dmeyerk@unmc.edu

or  Amy Filler-Katz

Nebraska Methodist Hospital
Omaha, NE;

Nebraska Medical Center, Omaha, NE

 SMALL CELL   "Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung
Cancer also Receiving Cisplatin and Etoposide
Credentialing required by all sites – currently complete at Bergan (C30610) * ARM
C CLOSED"
 III

Natasha Wilson, nwilson@mvcc.cc

 402-991-8070 x203

 ------------------------

Marcia Grafe                       402-483-2827 mgrafe@lmep.com

Missouri Valley Cancer Consortium, Omaha NE;

 Nebraska Cancer Research Center, Lincoln NE

 SMALL CELL  A Phase I Study of Weekly Doxorubicin and Oral Topotecan for Patients with Relapsed or Refractory Small Cell Lung Cancer (SCLC)  I

Deborah Meyer, RN, BGS

 (402) 559-6941

dmeyerk@unmc.edu or Beth Kos (Ricklefs)

 Nebraska Medical Center, Omaha, NE
         

Nebraska Oncology Society
c/o Nebraska Medical Association
Sarah Dunbar
Executive Director
233 South 13th Street Suite 1200
Lincoln, NE 68508
sarahd@nebmed.org (email)
402-474-4472 (phone)
402-474-2198 (fax)

Powered by Wild Apricot Membership Software